Related references
Note: Only part of the references are listed.Proficiency in homologous recombination repair is prerequisite for activation of G2-checkpoint at low radiation doses
Aashish Soni et al.
DNA REPAIR (2021)
Radiation-dose-dependent functional synergisms between ATM, ATR and DNA-PKcs in checkpoint control and resection in G2-phase
Emil Mladenov et al.
SCIENTIFIC REPORTS (2019)
Telomerase activation by genomic rearrangements in high-risk neuroblastoma
Martin Peifer et al.
NATURE (2015)
Temporal proteomics of NGF-TrkA signaling identifies an inhibitory role for the E3 ligase Cbl-b in neuroblastoma cell differentiation
Kristina B. Emdal et al.
SCIENCE SIGNALING (2015)
Temporal proteomics of NGF-TrkA signaling identifies an inhibitory role for the E3 ligase Cbl-b in neuroblastoma cell differentiation
Kristina B. Emdal et al.
SCIENCE SIGNALING (2015)
Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5-a population-based study
Gemma Gatta et al.
LANCET ONCOLOGY (2014)
Neuroblastoma in dialog with its stroma: NTRK1 is a regulator of cellular cross-talk with Schwann cells
Kristian W. Pajtler et al.
ONCOTARGET (2014)
The genetic landscape of high-risk neuroblastoma
Trevor J. Pugh et al.
NATURE GENETICS (2013)
Strategies for optimizing the response of cancer and normal tissues to radiation
Everett J. Moding et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Exon-level expression analyses identify MYCN and NTRK1 as major determinants of alternative exon usage and robustly predict primary neuroblastoma outcome
A. Schramm et al.
BRITISH JOURNAL OF CANCER (2012)
RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma
Kristina A. Cole et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The DNA-damage response in human biology and disease
Stephen P. Jackson et al.
NATURE (2009)
Identification of ALK as a major familial neuroblastoma predisposition gene
Yael P. Mosse et al.
NATURE (2008)
Activating mutations in ALK provide a therapeutic target in neuroblastoma
Rani E. George et al.
NATURE (2008)
Resistance to an irreversible epidermal growth factor receptor (EGFR) inhibitor in EGFR-Mutant lung cancer reveals novel treatment strategies
Zhiwei Yu et al.
CANCER RESEARCH (2007)
ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage
Shuhei Matsuoka et al.
SCIENCE (2007)
ATM regulates ATR chromatin loading in response to DNA double-strand breaks
M Cuadrado et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Microarray analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA- and TrkB-expressing neuroblastomas
JH Schulte et al.
ONCOGENE (2005)
Germline PHOX2B mutation in hereditary neuroblastoma
YP Mosse et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
DNA damage checkpoint control in cells exposed to ionizing radiation
G Iliakis et al.
ONCOGENE (2003)
Neuroblastoma: Biological insights into a clinical enigma
GM Brodeur
NATURE REVIEWS CANCER (2003)
Activation of Akt/protein kinase B overcomes a G2/M cell cycle checkpoint induced by DNA damage
ES Kandel et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
A role for PI 3-kinase and PKB activity in the G2/M phase of the cell cycle
E Shtivelman et al.
CURRENT BIOLOGY (2002)
Two molecularly distinct G2/M checkpoints are induced by ionizing irradiation
B Xu et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Share Paper
